Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#)

BIOLOGICAL3 trials

Sponsors

Sclnow Biotechnology Co., Ltd.

Conditions

Cerebral InfarctionHeart FailureOsteonecrosis of Femoral Head

Phase 1

The Study of Heart Failure With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-HF)

SuspendedNCT03180450

Sclnow Biotechnology Co., Ltd.Heart Failure

Start: 2025-12-31End: 2026-12-31Target: 60Updated: 2025-05-14

The Study of Early Stage Osteonecrosis of Femoral Head With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ONFH)

SuspendedNCT03180463

Sclnow Biotechnology Co., Ltd.Osteonecrosis of Femoral Head

Start: 2025-12-31End: 2026-12-31Target: 30Updated: 2025-05-14

The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ACI) in the Treatment of Acute Cerebral Infarction

SuspendedNCT03186456

Sclnow Biotechnology Co., Ltd.Cerebral Infarction

Start: 2025-12-31End: 2026-12-31Target: 40Updated: 2025-05-14